DRUG GENERATION Trademark

Trademark Overview


On Thursday, August 19, 2021, a trademark application was filed for DRUG GENERATION with the United States Patent and Trademark Office. The USPTO has given the DRUG GENERATION trademark a serial number of 90890980. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 3, 2023. This trademark is owned by Generate Biomedicines, Inc.. The DRUG GENERATION trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Pharmaceutical preparations for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders, but excluding DNA-based gene therapy; therapeutic agents for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders but excluding DNA-based gene therapy; therapeutic products for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatri...

Biological and chemical agents for scientific and research use
drug generation

General Information


Serial Number90890980
Word MarkDRUG GENERATION
Filing DateThursday, August 19, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 3, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 4, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders, but excluding DNA-based gene therapy; therapeutic agents for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders but excluding DNA-based gene therapy; therapeutic products for the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, endocrine diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders, but excluding DNA-based gene therapy
Goods and ServicesBiological and chemical agents for scientific and research use
Disclaimer with Predetermined Text"DRUG"

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, October 6, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGenerate Biomedicines, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142

Party NameGenerate Biomedicines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Monday, July 3, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 3, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 29, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 22, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 22, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 22, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 22, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 4, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 4, 2022PUBLISHED FOR OPPOSITION
Wednesday, September 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 30, 2022DIVISIONAL PROCESSING COMPLETE
Tuesday, July 12, 2022DIVISIONAL REQUEST RECEIVED
Wednesday, August 24, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 12, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 12, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 12, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 12, 2022TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, January 12, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 12, 2022NON-FINAL ACTION E-MAILED
Wednesday, January 12, 2022NON-FINAL ACTION WRITTEN
Wednesday, January 12, 2022ASSIGNED TO EXAMINER
Wednesday, October 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 23, 2021NEW APPLICATION ENTERED